Ryuzo Yamaguchi

1.3k citations
28 papers · 857 indexed · 1 hit paper · h-index 7
Topics
Pancreatic and Hepatic Oncology Research (8 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers)Colorectal and Anal Carcinomas (5 papers)
Journals
The LancetSHILAP Revista de lepidopterologíaPLoS ONE

In The Last Decade

Ryuzo Yamaguchi

21 papers receiving 850 citations

Hit Papers

Adjuvant chemotherapy of S-1 versus gemcitabine for resec...20162026201920222016200400600

Peers

Ryuzo Yamaguchi
Comparison fields: 5 of 48
  • Oncology 784
  • Surgery 413
  • Pulmonary and Respiratory Medicine 309
  • Epidemiology 252
  • Cancer Research 208
Replace Elizabeth A Lano with:
Elizabeth A Lano United States
Alexander Gluth Germany
Hideki Kamada Japan
Toshihide Imaizumi Japan
Berend R. Beumer Netherlands
Joyce Wong United States
K Bakkevold Norway
Akiko Todaka Japan
Arne Westgaard Norway
Maria Biglietto Italy
Ryuzo Yamaguchi relative to Elizabeth A Lano United States Elizabeth A Lano's profile →
Citations per field
00.5×4.3×
Elizabeth A Lano · 1×
Citations per year

Countries citing papers authored by Ryuzo Yamaguchi

Since Specialization
Citations

This map shows the geographic impact of Ryuzo Yamaguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryuzo Yamaguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryuzo Yamaguchi more than expected).

Fields of papers citing papers by Ryuzo Yamaguchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryuzo Yamaguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryuzo Yamaguchi. The network helps show where Ryuzo Yamaguchi may publish in the future.

Co-authorship network of co-authors of Ryuzo Yamaguchi

This figure shows the co-authorship network connecting the top 25 collaborators of Ryuzo Yamaguchi. A scholar is included among the top collaborators of Ryuzo Yamaguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryuzo Yamaguchi. Ryuzo Yamaguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 1
4 14
5 3
6 2
7 2
8 9
9 34
10 7
11 0
12
Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)breakdown →
742
13 12
14 1
15 2
16 2
17 10
18 0
19 3
20 0

About Ryuzo Yamaguchi

Ryuzo Yamaguchi is a scholar working on Gastroenterology, Oncology and Pulmonary and Respiratory Medicine, having authored 28 papers that have together received 857 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (8 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers) and Colorectal and Anal Carcinomas (5 papers). The work is most often cited by research in Oncology (784 citations), Cancer Research (208 citations) and Pulmonary and Respiratory Medicine (309 citations). Ryuzo Yamaguchi has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Koji Imai, Shoichi Hishinuma, Satoshi Hirano, Narikazu Boku, Akira Fukutomi, Yukiyasu Okamura, Hirohiko Sakamoto, Yasuo Ohashi, Yuji Kaneoka and Hitoshi Ojima. Their work appears in journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026